Peer review reports
From: Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment
Original Submission |
2 Feb 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
6 Apr 2021 |
Reviewed |
Reviewer Report
|
8 Apr 2021 |
Reviewed |
Reviewer Report
|
25 Apr 2021 |
Reviewed |
Reviewer Report
|
3 Jun 2021 |
Author responded |
Author comments - Lin Zhang
|
Resubmission - Version 6 |
3 Jun 2021 |
Submitted |
Manuscript version 6
|
28 Jul 2021 |
Reviewed |
Reviewer Report
|
31 Jul 2021 |
Reviewed |
Reviewer Report
|
23 Aug 2021 |
Author responded |
Author comments - Lin Zhang
|
Resubmission - Version 7 |
23 Aug 2021 |
Submitted |
Manuscript version 7
|
27 Oct 2021 |
Reviewed |
Reviewer Report
|
27 Nov 2021 |
Author responded |
Author comments - Lin Zhang
|
Resubmission - Version 8 |
27 Nov 2021 |
Submitted |
Manuscript version 8
|
30 Nov 2021 |
Reviewed |
Reviewer Report
|
Resubmission - Version 9 |
|
Submitted |
Manuscript version 9
|
Publishing |
8 Dec 2021 |
Editorially accepted |
|
28 Dec 2021 |
Article published |
10.1186/s12872-021-02414-7
|
Learn about peer review